Marcos Brasilino de Carvalho

Marcos Brasilino de Carvalho

Auto-generated profile, based on publicly available information

Marcos Brasilino de Carvalho

Hospital Heliópolis

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2013 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
AWAnnah Wyss
Annah Wyss
MHMia Hashibe
Mia Hashibe
SCShu-Chun Chuang
Shu-Chun Chuang
YLYuan-Chin Amy Lee
Yuan-Chin Amy Lee
ZZZuo-Feng Zhang
Zuo-Feng Zhang
AOAndrew F. Olshan
Andrew F. Olshan
Cigar and pipe smoking are considered risk factors for head and neck cancers, but the magnitude of effect estimates for these products has been imprecisely estimated. By using pooled data from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium (comprising 13,935 cases and 18,691 controls in 19 studies from 1981 to 2007), we applied hierarchical logistic regression to more precisely estimate odds ratios and 95% confidence intervals for cigarette, cigar, and pipe smoking separately, compared with reference groups of those who had never smoked each single product. Odds ratios for cigar and pipe smoking were stratified by ever cigarette smoking. We also considered effect estimates of smoking a single product exclusively versus never having smoked any product (reference group). Among never cigarette smokers, the odds ratio for ever cigar smoking was 2.54 (95% confidence interval (CI): 1.93, 3.34), and the odds ratio for ever pipe smoking was 2.08 (95% CI: 1.55, 2.81). These odds ratios increased with increasing frequency and duration of smoking (Ptrend ≤ 0.0001). Odds ratios for cigar and pipe smoking were not elevated among ever cigarette smokers. Head and neck cancer risk was elevated for those who reported exclusive cigar smoking (odds ratio = 3.49, 95% CI: 2.58, 4.73) or exclusive pipe smoking (odds ratio = 3.71, 95% CI: 2.59, 5.33). These results suggest that cigar and pipe smoking are independently associated with increased risk of head and neck cancers.

23 May 2006 in Head & Neck
Verified
Journal Article
Closed access
PDF file
GGGilka Jorge Figaro Gattás
Gilka Jorge Figaro Gattás
MCMarcos Brasilino de Carvalho
Marcos Brasilino de Carvalho
MSMaria Salete Siraque
Maria Salete Siraque
OCOtávio A. Curioni
Otávio A. Curioni
PKPriscila Kohler
Priscila Kohler
VWVictor Wünsch‐Filho
Victor Wünsch‐Filho

29 January 2014 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
RLRossana Verónica Mendoza López
Rossana Verónica Mendoza López
JLJosé Eduardo Levi
José Eduardo Levi
JEJose Eluf-Neto
Jose Eluf-Neto
RKRosalina Jorge Koifman
Rosalina Jorge Koifman
SKSergio Koifman
Sergio Koifman
VWVictor Wünsch-Filho
Victor Wünsch-Filho

1 June 2010 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
MBMaria Gabriela Haye Biazevic
Maria Gabriela Haye Biazevic
JAJosé Leopoldo Ferreira Antunes
José Leopoldo Ferreira Antunes
JTJanina Togni
Janina Togni
FAFabiana Paula de Andrade
Fabiana Paula de Andrade
MCMarcos Brasilino de Carvalho
Marcos Brasilino de Carvalho
VWVictor Wünsch-Filho
Victor Wünsch-Filho
This study aimed to assess the survival and life quality evolution of patients subjected to surgical excision of oral and oropharyngeal squamous cell carcinoma. Forty-seven patients treated at a Brazilian healthcare unit specialized in head and neck surgery between 2006 and 2007 were enrolled in the study. The gathering of data comprised reviewing hospital files and applying the University of Washington Quality of Life (UW-QOL) questionnaire previously and 1 year after the surgery. Comparative analysis used Poisson regression to assess factors associated with survival and a paired t-test to compare preoperative and 1-year postoperative QOL ratings. 1 year after surgery, 7 patients were not found (dropout of the cohort); 15 had died and 25 fulfilled the UW-QOL again. The risk of death was associated with having regional metastasis previously to surgery (relative risk=2.18; 95% confidence interval=1.09-5.17) and tumor size T3 or T4 (RR=2.30; 95%CI=1.05-5.04). Survivors presented significantly (p<0.05) poorer overall and domain-specific ratings of quality of life. Chewing presented the largest reduction: from 74.0 before surgery to 34.0 one year later. Anxiety was the only domain whose average rating increased (from 36.0 to 70.7). The prospective assessment of survival and quality of life may contribute to anticipate interventions aimed at reducing the incidence of functional limitations in patients with oral and oropharyngeal cancer.

18 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMarcelo dos Santos
Marcelo dos Santos
AMAna Maria da Cunha Mercante
Ana Maria da Cunha Mercante
ILIuri Drumond Louro
Iuri Drumond Louro
AGAntônio José Gonçalves
Antônio José Gonçalves
MCMarcos Brasilino de Carvalho
Marcos Brasilino de Carvalho
ASADRIANA MADEIRA ALVARES DA SILVA
ADRIANA MADEIRA ALVARES DA SILVA
Oral squamous cell carcinoma is an important cause of death and morbidity wordwide and effective prognostic markers are still to be discovered. HIF1α protein is associated with hypoxia response and neovascularization, essential conditions for solid tumors survival. The relationship between HIF1α expression, tumor progression and treatment response in head and neck cancer is still poorly understood. In this study, we investigated HIF1α expression by immunohistochemistry in tissue microarrays and its relationship with clinical findings, histopathological results and survival of 66 patients with squamous cell carcinoma of the lower mouth. Our results demonstrated that high HIF1α expression is associated with local disease-free survival, independently from the choice of treatment. Furthermore, high expression of HIF1α in patients treated with postoperative radiotherapy was associated with survival, therefore being a novel prognostic marker in squamous cell carcinoma of the mouth. Additionally, our results showed that MVD was associated with HIF1α expression and local disease relapse. These findings suggest that HIF1α expression can be used as a prognostic marker and predictor of postoperative radiotherapy response, helping the oncologist choose the best treatment for each patient.

30 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RDRoberta Lelis Dutra
Roberta Lelis Dutra
MCMarcos Brasilino de Carvalho
Marcos Brasilino de Carvalho
MSMarcelo dos Santos
Marcelo dos Santos
AMAna Maria da Cunha Mercante
Ana Maria da Cunha Mercante
DGDiana Gazito
Diana Gazito
ASADRIANA MADEIRA ALVARES DA SILVA
ADRIANA MADEIRA ALVARES DA SILVA
Fibroblast growth factor receptor 4 (FGFR4) is a member of a receptor tyrosine kinase family of enzymes involved in cell cycle control and proliferation. A common single nucleotide polymorphism (SNP) Gly388Arg variant has been associated with increased tumor cell motility and progression of breast cancer, head and neck cancer and soft tissue sarcomas. The present study evaluated the prognostic significance of FGFR4 in oral and oropharynx carcinomas, finding an association of FGFR4 expression and Gly388Arg genotype with tumor onset and prognosis. DNA from peripheral blood of 122 patients with oral and oropharyngeal squamous cell carcinomas was used to determine FGFR4 genotype by PCR-RFLP. Protein expression was assessed by immunohistochemistry (IHC) on paraffin-embedded tissue microarrays. Presence of allele Arg388 was associated with lymphatic embolization and with disease related premature death. In addition, FGFR4 low expression was related with lymph node positivity and premature relapse of disease, as well as disease related death. Our results propose FGFR4 profile, measured by the Gly388Arg genotype and expression, as a novel marker of prognosis in squamous cell carcinoma of the mouth and oropharynx.